About Doctor's Allergy Formula
Doctor's Allergy Formula is a Healthcare company based in Norcross (United States) founded in 2013, and was acquired by Bausch & Lomb in October 2015. It operates as a diagnostics for ocular allergies are developed using regional allergen panels. The company was acqui-hired. Its focus areas include Life Sciences, Immunology, In Vitro Diagnostic Tests and Allergies. Its competitors include Allergy Amulet, YorkTest, Microtest Diagnostics, ATANIS Biotech and DST and 4 more; 3 of its 9 listed competitors have raised funding.
Company details
Doctors Allergy Formula was founded in 2013 in Norcross, United States, focusing on medical diagnostics in the healthcare sector. An in-house test featuring a panel of 60 allergens adapted to various regional profiles is utilized to pinpoint causes of ocular allergies. Test results are delivered within 15 minutes. The company was acquired by Bausch Lomb in October 2015 for an undisclosed sum.
- Headquarters Norcross, United States
- SectorsHealthcare
- Website drsallergyformula.com
- Acquired by Bausch & Lomb (Oct 2015)
- Investors
- Acquired byBausch & Lomb
(Oct 2015)
Investors in Doctor's Allergy Formula
Doctor's Allergy Formula has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Bausch & Lomb.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | bausch.com | Bridgewater, United States |
Investor details for Doctors Allergy Formula
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Doctor's Allergy Formula
2 dated milestones of Doctor's Allergy Formula across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Doctor's Allergy Formula is founded.
- Exit Acquired by Bausch & Lomb.
Competitors of Doctor's Allergy Formula
Doctor's Allergy Formula has 9 listed competitors in our database, 3 of them funded. They include Allergy Amulet, YorkTest, Microtest Diagnostics, ATANIS Biotech and DST, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| allergyamulet.com | 2016 | Madison, United States | $12.57M | – | Portable food allergen sensors are offered via an online platform. | |
| yorktest.com | 1982 | York, United Kingdom | $12.03M | 38 | At-home food and allergy test kits are developed by YorkTest. | |
| microtestdx.com | 2002 | London, United Kingdom | $2.5M | 6 | Functions as an automated allergy testing service. | |
| atanis-biotech.com | 2021 | Sursee, Switzerland | – | – | Developer of a cell-based assay for the diagnosis of allergies | |
| dst-diagnostic.com | 2005 | Schwerin, Germany | – | 42 | Innovative in-vitro diagnostic solutions are developed by DST. | |
| immunovent.com | 2012 | New York, United States | – | – | Diagnostic tests for allergies are developed using mucosal brush samples. | |
| macroarraydx.com.ua | 2016 | Kiev, Ukraine | – | – | Allergen analyzers are provided for in-vitro IgE level determination. | |
| allergenis.com | 2017 | Hatfield, United States | – | – | Develops accurate allergy testing solutions for healthcare providers and patients. | |
| bangqibio.tcc.mode | 2020 | Suzhou, China | – | – | Instruments and reagents for immune disorder diagnosis are developed. |
Detailed competitors of Doctors Allergy Formula
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Immunology & Cancer Therapeutics
10 companies that operate in the same segment as Doctor's Allergy Formula (Immunology & Cancer Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | – | – | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Targeted therapies for cancer treatment are developed. | 2005 | Waltham, Massachusetts, United States | USD 198.29 M | USD 172.35 M | 270 | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Plasma-based biologics are developed for immune deficiency and infectious diseases. | 2005 | Ramsey, Minnesota, United States | USD 17.55 M | USD 510.17 M | 685 | |
Antibody drugs for cancer treatment are developed. | 2015 | Singapore, Singapore | USD 150 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | 2003 | United States | USD 171.85 M | USD 102.48 M | 338 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Doctor's Allergy Formula
Doctor's Allergy Formula was founded in 2013.
Doctor's Allergy Formula is headquartered in Norcross, United States. It is registered at Norcross, Georgia, United States.
Doctors Allergy Formula was founded in 2013 in Norcross, United States, focusing on medical diagnostics in the healthcare sector. An in-house test featuring a panel of 60 allergens adapted to various regional profiles is utilized to pinpoint causes of ocular allergies. Test results are delivered within 15 minutes. The company was acquired by Bausch Lomb in October 2015 for an undisclosed sum.
Doctor's Allergy Formula's top competitors include Allergy Amulet, ATANIS Biotech and YorkTest.
Doctor's Allergy Formula has 1 investor. Key investors include Bausch & Lomb.
Yes. Doctor's Allergy Formula was acquired by Bausch & Lomb in October 2015.